BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:Nanoscience Centre Seminar Series
SUMMARY:The Future of Personalized Medicine - Stefan Harre
 r - IBM Research
DTSTART;TZID=Europe/London:20140923T140000
DTEND;TZID=Europe/London:20140923T150000
UID:TALK54109AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/54109
DESCRIPTION:DNA-sequencing approaches the 1000-Dollar-Genome m
 ilestone allowing for decoding a complete human ge
 nome with unmatched speed and at low cost. Increas
 ed sequencing efficiency yields massive amounts of
  genomic data. Analysis of this data eventually en
 ables understanding the role of each DNA segment a
 nd its correlation with the risk of developing a c
 ertain disease. New drug targets are identified an
 d validated continuously and can be matched with a
  personalized genetic risk assessment. Access to t
 his information triggers fundamental questions for
  doctors and patients alike: What are the chances 
 of an outbreak? Are drugs available? What is the b
 est combination of prevention and treatment? In or
 der to provide answers\, technologies for discover
 ing novel drugs\, for improving existing drugs and
  for their intelligent use in an increasingly comp
 lex environment\, will have to be revolutionized. 
 The path from fast and cheap personalized sequenci
 ng via genomics big data analysis towards personal
  prevention and treatment will reshape medicine as
  we know it. IBM Research works at the forefront o
 f this process: we develop bionanosensor chips for
  next-generation DNA-sequencing and drug discovery
 \, and we employ supercomputers for life sciences 
 research\, genomics analysis and smarter healthcar
 e. We strive to re-invent personalized medicine\, 
 the next big thing emerging from marrying nanotech
 nology\, biotechnology and the power of big data. 
 In this talk I will describe IBM’s engagement in b
 iospace research with a special focus on two of ou
 r bionanotechnology flagship projects: (I) IBM’s “
 DNA Transistor”\, a 4 th -generation nanopore-base
 d DNA-sequencing chip\, and (II) the Bionanotechno
 logy Research Program” of IBM Research Australia w
 hich aims at developing novel ways for drug discov
 ery and screening.
LOCATION:Kapitza Building\, MRC Seminar Room\, Cavendish La
 boratory\, Department of Physics
CONTACT:Jerome Charmet
END:VEVENT
END:VCALENDAR